Kwang‐Hee Shin

550 total citations
51 papers, 404 citations indexed

About

Kwang‐Hee Shin is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, Kwang‐Hee Shin has authored 51 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 11 papers in Pharmacology and 8 papers in Oncology. Recurrent topics in Kwang‐Hee Shin's work include Pharmacogenetics and Drug Metabolism (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Kwang‐Hee Shin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Kwang‐Hee Shin collaborates with scholars based in South Korea, United States and Ethiopia. Kwang‐Hee Shin's co-authors include Hyeon Cheol Jeong, Tae‐Eun Kim, Jeong-Eun Park, Kyung‐Sang Yu, Joo‐Youn Cho, In‐Jin Jang, Min‐Gul Kim, Kyoung Soo Lim, Sang‐Goo Shin and Yoon‐Jee Chae and has published in prestigious journals such as PLoS ONE, Brain Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Kwang‐Hee Shin

46 papers receiving 399 citations

Peers

Countries citing papers authored by Kwang‐Hee Shin

Since Specialization

Citations

This map shows the geographic impact of Kwang‐Hee Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwang‐Hee Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwang‐Hee Shin more than expected).

Fields of papers citing papers by Kwang‐Hee Shin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwang‐Hee Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwang‐Hee Shin. The network helps show where Kwang‐Hee Shin may publish in the future.

Co-authorship network of co-authors of Kwang‐Hee Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Kwang‐Hee Shin. A scholar is included among the top collaborators of Kwang‐Hee Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwang‐Hee Shin. Kwang‐Hee Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Research on unintroduced new drugs in South Korea from 2011 to 2020: approaches to prioritization and strategy 2024 ·Translational and Clinical Pharmacology ·(unknown), (unknown), (unknown), Tae‐Eun Kim, Kwang‐Hee Shin, (unknown), Hyewon Chung, (unknown), (unknown), Namyi Gu	0
2	Population pharmacokinetic modeling of sufentanil in adult Korean patients undergoing cardiopulmonary bypass surgery 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Kuk Hui Son, (unknown), (unknown), (unknown), (unknown), Dongseong Shin, Kwang‐Hee Shin	3
3	Metabolomic Profiles in Patients with Cervical Cancer Undergoing Cisplatin and Radiation Therapy 2024 ·Biomolecules & Therapeutics ·(unknown), Suin Kim, Ji‐Young Jeon, Min‐Gul Kim, Sun Young Lee, Kwang‐Hee Shin	3
4	Strong inhibition of organic cation transporter 2 by flavonoids and attenuation effects on cisplatin-induced cytotoxicity 2023 ·Chemico-Biological Interactions ·Kwang‐Hee Shin, Kyeong‐Ryoon Lee, Minji Kang, Yoon‐Jee Chae	4
5	Prediction of the Drug–Drug Interaction Potential between Tegoprazan and Amoxicillin/Clarithromycin Using the Physiologically Based Pharmacokinetic and Pharmacodynamic Model 2023 ·Pharmaceuticals ·(unknown), Hyeon Cheol Jeong, Min‐Gul Kim, Kwang‐Hee Shin	2
6	Signal Detection of Adverse Event of Metoclopramide in Korea Adverse Event Reporting System (KAERS) 2023 ·Korean Journal of Clinical Pharmacy ·(unknown), (unknown), (unknown), Kwang‐Hee Shin	0
7	Drug–Drug interactions of docetaxel in patients with breast cancer based on insurance claims data 2023 ·PLoS ONE ·Kwang‐Hee Shin, Young‐Mi Ah, (unknown), (unknown)	0
8	Determination of Sufentanil in Human Plasma Using Ultra-highPerformance Liquid Chromatography Coupled with Tandem MassSpectrometry (UPLC–MS/MS) 2023 ·Current Analytical Chemistry ·(unknown), Suin Kim, Dongseong Shin, Kwang‐Hee Shin	1
9	Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations 2022 ·Pharmaceutics ·Hyeon Cheol Jeong, Min‐Gul Kim, (unknown), Kyeong‐Ryoon Lee, (unknown), Im‐Sook Song, Kwang‐Hee Shin	9
10	A compatibility evaluation between the physiologically based pharmacokinetic (PBPK) model and the compartmental PK model using the lumping method with real cases 2022 ·Frontiers in Pharmacology ·(unknown), Won-Ho Kang, (unknown), Jae Kyoung Kim, Kwang‐Hee Shin, Jung‐woo Chae, Hwi‐yeol Yun	5
11	Comparison of Efficacy and Safety of Statin–Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies 2021 ·American Journal of Cardiovascular Drugs ·Kwang‐Hee Shin, (unknown)	7
12	<p>Population pharmacokinetic analysis of tramadol and <em>O</em>-desmethyltramadol with genetic polymorphism of <em>CYP2D6</em></p> 2019 ·Drug Design Development and Therapy ·(unknown), (unknown), Jung‐Woo Bae, Sooyeun Lee, Kwang‐Hee Shin	14
13	Metabolite changes in risk of type 2 diabetes mellitus in cohort studies: A systematic review and meta-analysis 2018 ·Diabetes Research and Clinical Practice ·Jeong-Eun Park, (unknown), (unknown), Kwang‐Hee Shin	25
14	Association of TNF-alpha G-308A gene polymorphism with depression: a meta-analysis 2017 ·Neuropsychiatric Disease and Treatment ·Kwang‐Hee Shin, Hyeon Cheol Jeong, Dong‐Hee Choi, Sung Nyun Kim, Taeeun Kim	9
15	An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects 2014 ·Investigational New Drugs ·Kwang‐Hee Shin, Kyoung Soo Lim, Howard Lee, In‐Jin Jang, Kyung‐Sang Yu	8
16	Assessment of the Effect of Mirodenafil on the Hemodynamics of Healthy Male Korean Volunteers Administered Tamsulosin: A Randomized, Double-Blind, Placebo-Controlled, 2-Period Crossover Study 2012 ·Clinical Therapeutics ·Namyi Gu, Jae Woo Kim, Kyoung Soo Lim, Kwang‐Hee Shin, Taeeun Kim, Bongyong Lee, Sang‐Goo Shin, In‐Jin Jang, Kyung‐Sang Yu	6
17	Assessment of the Drug–Drug Interactions Between Fimasartan and Hydrochlorothiazide in Healthy Volunteers 2011 ·Journal of Cardiovascular Pharmacology ·Hyewon Jeon, Kyoung Soo Lim, Kwang‐Hee Shin, Jae Woo Kim, Seo Hyun Yoon, Joo‐Youn Cho, Sang‐Goo Shin, In‐Jin Jang, Kyung‐Sang Yu	21
18	Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: A single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers 2009 ·Clinical Therapeutics ·Bo‐Hyung Kim, Kwang‐Hee Shin, Jae Woo Kim, Kyoung Soo Lim, Kyu‐pyo Kim, Jung‐Ryul Kim, Joo‐Youn Cho, Sang‐Goo Shin, In‐Jin Jang, Kyung‐Sang Yu	11
19	Effect of ketoconazole on the pharmacokinetics of udenafil in healthy Korean subjects 2009 ·British Journal of Clinical Pharmacology ·Kwang‐Hee Shin, (unknown), Bo‐Hyung Kim, Tae‐Eun Kim, (unknown), Joo‐Youn Cho, In‐Jin Jang, Sang‐Goo Shin, Kyung‐Sang Yu	6
20	Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: A dose—block-randomized, double-blind, placebo-controlled, ascending single-dose, phase I study 2008 ·Clinical Therapeutics ·Kyoung Soo Lim, Jung‐Ryul Kim, Yun‐Jung Choi, Kwang‐Hee Shin, Kyu‐pyo Kim, Jang Hee Hong, Joo‐Youn Cho, Hyunsuk Shin, Kyung‐Sang Yu, Sang‐Goo Shin, Obin Kwon, (unknown), (unknown), In‐Jin Jang	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact